<DOC>
	<DOCNO>NCT02557594</DOCNO>
	<brief_summary>This Phase I clinical study evaluate safety pharmacokinetics DA-2802 319mg Viread 300mg single oral dose healthy male volunteer .</brief_summary>
	<brief_title>Clinical Trial Assess Safety Pharmacokinetics DA-2802 319mg Viread 300mg Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Age 20 50 , healthy male subject ( screen ) Body weight 55kg , BMI 18.0 27.0 Volunteer totally understand progress clinical trial , make decision free , signed consent form follow progress . Volunteer past present history disease follow . ( liver include hepatitis virus carrier , kidney , neurology , immunology , pulmonary , endocrine , hematooncology , urinary , skeletomuscular , cardiovascular , mental disorder ) Volunteer GI tract disease ( Crohn 's disease , ulcer , acute chronic pancreatitis ) surgery ( appendectomy , hernioplasty exclude ) Genetic disorder glucosegalactose malabsorption , Lapp lactose deficiency , galactose intolerance contraindication Viread Volunteer hypersensitivity reaction medicine include Tenofovir , Aspirin , antibiotic exceed 1.5 time normal range AST , ALT screen test randomization history drug abuse , positive urine drug screen ETC drug herbal medicine within 2 week first administration OTC drug vitamin preparation within week first administration Participation clinical trial involve investigational drug within 3 month Volunteer whole blood donation 2 month , component blood donation transfusion 1 month Regular alcohol consumption ( 21 units/week , 1unit=10g pure alcohol ) volunteer abstain drink study Volunteers smoke 10 cigarette per day abstain smoking study ( 24hr admission discharge ) Volunteers grapefruit contain food 24hr admission discharge abstain grapefruit contain food Volunteers use adequate contraception method pregnancy plan volunteer abstain caffeine contain food ( coffee , tea , soft drink etc ) study condition , view investigator , would interfere study participation</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Hepatitis B</keyword>
</DOC>